Filing Flows › Balchem (BCPC) › Q2 2026 › vs Q1 2026
Balchem (BCPC) Q2 2026 vs Q1 2026 (quarter over quarter)
Balchem's revenue rose $13.3M (+5%) from $271M in Q1 2026 to $284M in Q2 2026. The biggest changes: Product Sales Revenue +$13.1M (+5%); Royalty Revenue +$141K (+29%). Gross margin 36.5% against 37.3% (-0.8 pts).
Balchem, Q2 2026: revenue $284M (+11% year over year), operating margin 20.9%, net earnings $44.6M, operating cash flow $46.7M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 36.5% | 37.3% | -0.8 pts |
| Operating margin | 20.9% | 20.5% | +0.3 pts |
| Net margin | 15.7% | 14.9% | +0.8 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product Sales Revenue | $283M | $270M | $13.1M | +5% |
| Royalty Revenue | $634K | $493K | $141K | +29% |
| Revenue | $284M | $271M | $13.3M | +5% |
| Gross profit | $104M | $101M | $2.6M | +3% |
| Cost of revenue | $180M | $170M | $10.7M | +6% |
| Operating profit | $59.2M | $55.6M | $3.6M | +6% |
| Operating expenses | $44.5M | $45.5M | −$996K | -2% |
| Pre-tax earnings | $57.8M | $52.5M | $5.3M | +10% |
| Other expense, net | $1.4M | $3.1M | −$1.7M | -54% |
| Research & development | $4.5M | $5.9M | −$1.3M | -23% |
| Sales & marketing | $21.1M | $21.1M | $41K | +0.2% |
| General & admin | $18.8M | $18.5M | $310K | +2% |
| Net earnings | $44.6M | $40.3M | $4.3M | +11% |
| Income tax | $13.2M | $12.2M | $929K | +8% |
| Depreciation & amortization | $12.2M | $12.5M | −$271K | -2% |
| Share-based compensation | $5.9M | $5.4M | $565K | +11% |
| Working capital & other | $16.0M | $18.1M | −$2.0M | -11% |
| Operating cash flow | $46.7M | $40.1M | $6.7M | +17% |
Questions
How much did Balchem's revenue grow quarter over quarter in Q2 2026?
Balchem's revenue rose $13.3M (+5%) from $271M in Q1 2026 to $284M in Q2 2026.
What drove Balchem's revenue change in Q2 2026?
Product Sales Revenue +$13.1M (+5%); Royalty Revenue +$141K (+29%).